377 related articles for article (PubMed ID: 31932268)
1. Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome.
Cabañas R; Ramírez E; Sendagorta E; Alamar R; Barranco R; Blanca-López N; Doña I; Fernández J; Garcia-Nunez I; García-Samaniego J; Lopez-Rico R; Marín-Serrano E; Mérida C; Moya M; Ortega-Rodríguez NR; Rivas Becerra B; Rojas-Perez-Ezquerra P; Sánchez-González MJ; Vega-Cabrera C; Vila-Albelda C; Bellón T
J Investig Allergol Clin Immunol; 2020; 30(4):229-253. PubMed ID: 31932268
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment.
Cabañas R; Calderón O; Ramírez E; Fiandor A; Caballero T; Heredia R; Herranz P; Madero R; Quirce S; Bellón T
Clin Exp Allergy; 2018 Mar; 48(3):325-333. PubMed ID: 29265576
[TBL] [Abstract][Full Text] [Related]
3. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module.
Wolfson AR; Zhou L; Li Y; Phadke NA; Chow OA; Blumenthal KG
J Allergy Clin Immunol Pract; 2019 Feb; 7(2):633-640. PubMed ID: 30176295
[TBL] [Abstract][Full Text] [Related]
4. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.
de Groot AC
Contact Dermatitis; 2022 Jun; 86(6):443-479. PubMed ID: 35233782
[TBL] [Abstract][Full Text] [Related]
5. Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.
Brüggen MC; Walsh S; Ameri MM; Anasiewicz N; Maverakis E; French LE; Ingen-Housz-Oro S; ; Abe R; Ardern-Jones M; Assier H; Barbaud A; Bensaid B; Bernal W; Bernier C; Brassard A; Brezinová E; Cabañas R; Cardones A; Chu CY; Chua SL; Descamps V; Didona B; Divito SJ; Dodiuk-Gad R; Elman S; Gaspar K; Mortz CG; Hama N; Lee HY; Horváth B; Jörg L; Kaffenberger BH; Kucinskiene V; Lebrun-Vignes B; Lehloenya RJ; Meyersburg D; Micheletti R; Milpied B; Miyagawa F; Mostaghimi A; Nägeli M; Naldi L; Oppel E; Phillips EJ; Pirani T; Ranki A; Mälkönen T; Rosenbach M; Salavastru C; Staumont-Salle D; Sandberg H; Setterfield J; Shinkai K; Shiohara T; Soria A; Tartar D; Tiplica GS; Traidl S; Vorobyev A; von Wachter C; Worswick S; Cho YT
JAMA Dermatol; 2024 Jan; 160(1):37-44. PubMed ID: 37966824
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
7. How to identify DRESS, drug reaction with eosinophilia and systemic symptoms?
Sarajärvi P; Kubin M; Tasanen K; Huilaja L
Duodecim; 2017; 133(1):43-51. PubMed ID: 29199808
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
[TBL] [Abstract][Full Text] [Related]
9. Potential Biomarker Identification by RNA-Seq Analysis in Antibiotic-Related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Pilot Study.
Teo YX; Haw WY; Vallejo A; McGuire C; Woo J; Friedmann PS; Polak ME; Ardern-Jones MR
Toxicol Sci; 2022 Aug; 189(1):20-31. PubMed ID: 35703984
[TBL] [Abstract][Full Text] [Related]
10. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
Medina-Cáliz I; Sanabria-Cabrera J; Villanueva-Paz M; Aukštikalnė L; Stephens C; Robles-Díaz M; Pinazo-Bandera JM; García-Cortes M; Conde I; Soriano G; Bessone F; Hernandez N; Nunes V; Paraná R; Lucena MI; Andrade RJ; Niu H; Alvarez-Alvarez I
Arch Toxicol; 2024 Jan; 98(1):303-325. PubMed ID: 38051367
[TBL] [Abstract][Full Text] [Related]
11. Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
Chatproedprai S; Tiasiri N; Chantawarangkul K; Wananukul S
J Dermatol; 2024 Apr; 51(4):509-517. PubMed ID: 38214543
[TBL] [Abstract][Full Text] [Related]
12. Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review.
E L omairi N; Abourazzak S; Chaouki S; Atmani S; Hida M
Pan Afr Med J; 2014; 18():9. PubMed ID: 25360193
[TBL] [Abstract][Full Text] [Related]
13. DRESS characteristics according to the causative medication.
Chaabane A; Romdhane HB; Fadhel NB; Fredj NB; Ammar H; Boughattas N; Chadly Z; Aouam K
Eur J Clin Pharmacol; 2022 Sep; 78(9):1503-1510. PubMed ID: 35726027
[TBL] [Abstract][Full Text] [Related]
14. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
Fernando SL
Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
[TBL] [Abstract][Full Text] [Related]
15. Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab.
Chua GT; Rosa Duque JS; Chong PCY; Lee PPW; Lau YL; Ho MHK
Eur Ann Allergy Clin Immunol; 2018 Nov; 50(6):273-276. PubMed ID: 29384118
[TBL] [Abstract][Full Text] [Related]
16. Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: A retrospective study.
Soria A; Bernier C; Veyrac G; Barbaud A; Puymirat E; Milpied B
J Am Acad Dermatol; 2020 Mar; 82(3):606-611. PubMed ID: 31562941
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide Induced Atypical DRESS: A Case Report and Literature Review.
Fatima M; Azimi SS; Ashwini S; Radhakrishna MH
Mediterr J Rheumatol; 2023 Mar; 34(1):91-96. PubMed ID: 37223589
[TBL] [Abstract][Full Text] [Related]
18. Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse.
Turney R; Skittrall JP; Donovan J; Agranoff D
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438678
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
J Am Acad Dermatol; 2024 May; 90(5):885-908. PubMed ID: 37516359
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.
Sharifzadeh S; Mohammadpour AH; Tavanaee A; Elyasi S
Eur J Clin Pharmacol; 2021 Mar; 77(3):275-289. PubMed ID: 33025080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
